Analysis of the structure of mycolic acids of Mycobacterium simiae reveals a particular composition of α-mycolates in strain 'habana' TMC 5135, considered as immunogenic in tuberculosis and leprosy

Microbiology

Volumn 153, Issue 12, 2007, Pages 4159-4165

  Mederos, Lilian ^a   Valdivia, José A ^a   Valero Guillén, Pedro L ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN; MYCOLIC ACID; MYCOLIC ACID METHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM CULTURE; GENETIC SUSCEPTIBILITY; GRAM POSITIVE BACTERIUM; IMMUNOGENICITY; MOLECULAR GENETICS; MYCOBACTERIUM SIMIAE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; STRAIN DIFFERENCE; STRUCTURE ANALYSIS;

ANIMALS; BACTERIAL VACCINES; HUMANS; LEPROSY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MYCOBACTERIA, ATYPICAL; MYCOLIC ACIDS; SPECIES SPECIFICITY; TUBERCULOSIS VACCINES;

MYCOBACTERIUM SIMIAE;

EID: 37449003873     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2007/011262-0     Document Type: Article

References (33)

1. Astola, J., Muñoz, M., Sempere, M., Coll, P., Luquin, M. & Valero-Guillén, P. L. (2002). The HPLC-double-cluster pattern of some Mycobacterium gordonae strains is due to their dicarboxy-mycolate content. Microbiology 148, 3119-3127.
2. Baess, I. & Magnusson, M. (1982). Classification of Mycobacterium simiae by means of comparative reciprocal intradermal sensitin testing on guinea pigs and deoxyribonucleic acid hybridization. Acta Pathol Microbiol Immunol Scand [B] 90, 101-107.
3. Barry, C. E., III, Lee, R. E. Mdluli, K., Sampson, A. E., Schroeder, B. G., Slayden, R. A. & Yuan, Y. (1998). Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res 37, 143-179.
4. + T cells. Nature 372, 691-694.
5. Bhatt, A., Fujiwara, N., Bhatt, K, Gurcha, S. S., Kremer, L., Chang, B., Chan, J., Porcelli, S. A., Kobayashi, K & other authors (2007). Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A 104, 5157-5162.
6. Brennan, P. J. & Nikaido, H. (1995). The envelope of mycobacteria. Annu Rev Biochem 64, 29-63.
7. Butler, W. R. & Guthertz, L. S. (2001). Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev 14, 704-726.
8. Daft, M. & Draper, P. (1998). The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39, 131-203.
9. de la Salle, H., Mariotti, S., Angenieux, C., Gilleron, M., Garcia-Alles, L.-F., Malm, D., Berg, T., Paoletti, S., Maître, B. & other authors (2005). Assistance of microbial glycolipid antigen processing by CDIe. Science 310, 1321-1324.
10. Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M. A., Yu, K., Quémard, A., Smith, I. & Daft, M. (2000). Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36, 630-637.
11. Falkinham, J. O., III (1996). Epidemiology of infection by non-tuberculous mycobacteria. Clin Microbiol Rev 9, 177-215.
12. Geisel, R. E., Sakamoto, K., Russel, D. G. & Rhoades, E. R. (2005). In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates. J Immunol 174, 5007-5015.
13. Khoo, K. H., Chaterjee, D., Dell, A., Morris, H. R., Brennan, P. J. & Draper, P. (1996). Novel O-methylated terminal glucuronic acid characterizes the polar glycopeptidolipids of Mycobacterium habana TMC 5135. J Biol Chem 271, 12333-12342.
14. Mederos, L. M., Gutiérrez, A. M. & Valdivia, J. A. (1992). Utilization of a new culture medium in biochemical tests for the mycobacterial classification. Mem Inst Oswaldo Cruz 87, 441.
15. Mederos, L. M., Valdivia, J. A. & Valero-Guillén, P. L. (1998). Analysis of lipids reveals differences between 'Mycobacterium habana' and Mycobacterium simiae. Microbiology 144, 1181-1188.
16. Mederos, L. M., Valdivia, J. A. & Valero-Guillén, P. L. (2006). Lipids of 'Mycobacterium habana', a synonym of Mycobacterium simiae with vaccine potential. Tuberculosis (Edinb) 86, 324-329.
17. Meissner, G. & Schröder, K. H. (1975). Relationships between Mycobacterium simiae and Mycobacterium habana. Am Rev Respir Dis 111, 196-200.
18. Minnikin, D. E. (1982). Lipids: complex lipids. In The Biology of the Mycobacteria, vol. 1, pp. 95-184. Edited by C. Ratledge & J. L. Stanford. London: Academic Press.
19. Minnikin, D. E., Hutchinson, I. G., Caldicott, A. B. & Goodfellow, M. (1980). Thin-layer chromatography of methanolysates of mycolic-acid containing bacteria. J Chromatogr 188, 221-233.
20. Minnikin, D. E., Minnikin, S. M., Parlett, J. H., Goodfellow, M. & Magnusson, M. (1984). Mycolic acid patterns of some species of Mycobacterium. Arch Microbiol 139, 225-231.
21. Rao, V., Fujiwara, N., Porcelli, S. A. & Glickman, M. S. (2005). Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201, 535-543.
22. Rao, V., Gao, F., Chen, B., Jacobs, W. R., Jr & Glickman, M. S. (2006). Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest 116, 1660-1667.
23. Rhoades, E., Hsu, F. F., Torrelles, J. B., Turk J., Chaterjee, D. & Russell, D. G. (2003). Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol 48, 875-888.
24. Riley, L. W. (2006). Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope and pathogenesis. J Clin Invest 116, 1475-1478.
25. Schaible, U. E. & Kaufmann, S. H. E. (2000). CD1 and CD1-restricted T cells in infections with intraceUular bacteria. Trends Microbiol 8, 419-425.
26. Takayama, K., Wang, C. & Besra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18, 81-101.
27. Valdés, I., Montoro, E., Valdidia, J. A., Aguilar, D., Orozco, E. & Hernández-Pando, R. (2007a). Immunogenicity induced by three strains of Mycobacterium habana in BALB/c model of progressive pulmonary tuberculosis. In TB07 Vaccines. International Workshop on Tuberculosis Vaccines. Program and Abstract Book. P37.
28. Valdés, I., Montoro, E., Valdidia, J. A., Orozco, E., Aguilar, D. & Hernández-Pando, R. (2007b). Virulence of Mycobacterium habana strains in a BALB/c model of progressive pulmonary tuberculosis. In TB07 Vaccines. International Workshop on Tuberculosis Vaccines. Program and Abstract Book. P38.
29. Valdivia, J. A. (1973). Mycobacterium habana: clinical and epidemiological significance. Ann Soc Belg Med Trop 53, 263-266.
30. Watanabe, M., Ohta, A., Sasaki, A. & Minnikin, D. E. (1999). Structure of a new glycolipid from the Mycobacterium avium-Mycobacterium intracellulare complex. J Bacteriol 181, 2293-2297.
31. Watanabe, M., Aoyagi, Y., Ridell, M. & Minnikin, D. E. (2001). Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147, 1825-1837.
32. Watanabe, M., Aoyagi, Y., Mitome, H., Fujita, T., Naoki, H., Ridell, M. & Minnikin, D. E. (2002). Location of functional groups in mycobacterial meroaldhyde chains; the recognition of new structural principles in mycolic acids. Microbiology 148, 1881-1902.
33. Weiszfeiler, J. G. & Karczag, E. (1976). Synonymy of Mycobacterium simiae Karasseva et al. 1965 and Mycobacterium habana Valdivia et al. 1971. Int J Syst Bacteriol 26, 474-477.